首页> 外文期刊>Journal of Clinical Oncology >Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas.
【24h】

Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas.

机译:小儿骨肉瘤中c-kit基因位点等位基因失衡和c-kit过表达的免疫组化对预后的意义。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: Since the recent development of biologic agents targeting oncogenes, increasing attention has been focused on determining the role of tyrosine kinase receptors in the pathogenesis of tumors. Our study was designed to investigate the status of region 4q12, which contains the candidate gene c-kit, and the expression of c-kit by immunohistochemistry (IHC). PATIENTS AND METHODS: Paired blood and biopsy specimens of 68 children treated for high-grade primary osteosarcomas were collected. Microsatellite analysis at two genomic sites containing c-kit gene was performed on paired DNA using a sensible fluorescent polymerase chain reaction technology. To confirm the DNA data, we studied c-kit protein expression by IHC in 56 available paraffin-embedded tumor tissues. RESULTS: The frequency of allelic imbalance (AI) at locus 4q12 was 39% in the overall population. In agreement with previous studies, we did not detect microsatellite instability, allowing us to hypothesize that this pathway is not implicated. Furthermore, the normal status at locus 4q12 was associated with a significantly better survival in the whole osteosarcoma population (P = .05). IHC overexpression of c-kit was concordant in all cases presenting an AI. However, normal status at locus 4q12 was correlated to an absence of c-kit protein expression in 19 (65.5%) of 29 informative cases. CONCLUSION: Allelotyping of locus 4q12, which contains the c-kit gene, could help pediatric osteosarcoma prognostic screening and showed a strong correlation with overexpression of c-kit protein. These results allowed us to hypothesize that, in some cases, a mutation of c-kit gene could lead to a protein overexpression.
机译:目的:自从针对癌基因的生物制剂的最新发展以来,越来越多的注意力集中在确定酪氨酸激酶受体在肿瘤发病机理中的作用。我们的研究旨在调查包含候选基因c-kit的4q12区域的状态,以及通过免疫组织化学(IHC)检测c-kit的表达。患者与方法:收集了68例接受高级原发性骨肉瘤治疗的儿童的血液和活检标本。使用明智的荧光聚合酶链反应技术,在配对的DNA上对包含c-kit基因的两个基因组位点进行了微卫星分析。为了确认DNA数据,我们研究了IHC在56种可用石蜡包埋的肿瘤组织中表达的c-kit蛋白。结果:在总人口中,第4q12位点的等位基因失衡(AI)频率为39%。与以前的研究一致,我们没有检测到微卫星的不稳定性,因此我们可以假设该途径没有涉及。此外,基因座4q12处的正常状态与整个骨肉瘤人群的生存率显着提高相关(P = .05)。 IHC在表达AI的所有情况下均过度表达c-kit。然而,在29例资料丰富的病例中,有19例(65.5%)处于4q12基因座的正常状态与缺乏c-kit蛋白表达有关。结论:含有c-kit基因的基因座4q12的变型可以帮助小儿骨肉瘤的预后筛查,并且与c-kit蛋白的过表达密切相关。这些结果使我们可以假设,在某些情况下,c-kit基因的突变可能导致蛋白质过表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号